Neuroprotection by a selective oestrogen receptor {beta} agonist in a mouse model of global ischaemia

Hilary Carswell, I.M. Macrae, L. Gallagher, E. Harrop, K.J. Horsburgh

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

The present study employs selective estrogen receptor (ER) agonists to determine whether 17-estradiol-induced neuroprotection in global ischemia is receptor mediated and, if so, which subtype of receptor (ERα or ER) is predominantly responsible. Halothane-anesthetized female C57Bl/6J mice were ovariectomized, and osmotic minipumps containing ER agonist diarylpropiolnitrile (DPN) (8 mg·kg–1·day–1, n = 12) or vehicle (50% DMSO in 0.9% saline) (n = 9) or ERα agonist propyl pyrazole triol (PPT) (2 mg·kg–1·day–1, n = 13) or vehicle (50% DMSO in 0.9% saline) (n = 10) were implanted subcutaneously. One week later transient global ischemia was induced by bilateral carotid artery occlusion under halothane anesthesia, and the mice were perfusion fixed 72 h later. ER agonist DPN significantly reduced ischemic damage by 70% in the caudate nucleus and 55% in the CA1 region compared with vehicle controls (P < 0.05, Mann-Whitney U-statistic). In contrast, pretreatment with the ERα agonist PPT had no effect on the extent of neuronal damage compared with controls. The data indicate a significant estrogen receptor-mediated neuroprotection in a global cerebral ischemia model involving ER.
Original languageEnglish
Article numberIDS Number: 854IH
Pages (from-to)H1501-H1504
Number of pages5
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume287
Issue number4
Early online date20 May 2004
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Estrogen Receptor beta
Estrogens
Ischemia
Estrogen Receptors
Halothane
Dimethyl Sulfoxide
Caudate Nucleus
Brain Ischemia
Carotid Arteries
Estradiol
Anesthesia
Perfusion
Neuroprotection

Keywords

  • neuroprotector
  • oestrogen receptor
  • mouse model
  • global ischaemia

Cite this

@article{8710b549abcf41b3a6eec7c5c415dac7,
title = "Neuroprotection by a selective oestrogen receptor {beta} agonist in a mouse model of global ischaemia",
abstract = "The present study employs selective estrogen receptor (ER) agonists to determine whether 17-estradiol-induced neuroprotection in global ischemia is receptor mediated and, if so, which subtype of receptor (ERα or ER) is predominantly responsible. Halothane-anesthetized female C57Bl/6J mice were ovariectomized, and osmotic minipumps containing ER agonist diarylpropiolnitrile (DPN) (8 mg·kg–1·day–1, n = 12) or vehicle (50{\%} DMSO in 0.9{\%} saline) (n = 9) or ERα agonist propyl pyrazole triol (PPT) (2 mg·kg–1·day–1, n = 13) or vehicle (50{\%} DMSO in 0.9{\%} saline) (n = 10) were implanted subcutaneously. One week later transient global ischemia was induced by bilateral carotid artery occlusion under halothane anesthesia, and the mice were perfusion fixed 72 h later. ER agonist DPN significantly reduced ischemic damage by 70{\%} in the caudate nucleus and 55{\%} in the CA1 region compared with vehicle controls (P < 0.05, Mann-Whitney U-statistic). In contrast, pretreatment with the ERα agonist PPT had no effect on the extent of neuronal damage compared with controls. The data indicate a significant estrogen receptor-mediated neuroprotection in a global cerebral ischemia model involving ER.",
keywords = "neuroprotector, oestrogen receptor , mouse model, global ischaemia",
author = "Hilary Carswell and I.M. Macrae and L. Gallagher and E. Harrop and K.J. Horsburgh",
year = "2004",
month = "10",
doi = "10.1152/ajpheart.00227.2004",
language = "English",
volume = "287",
pages = "H1501--H1504",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
number = "4",

}

Neuroprotection by a selective oestrogen receptor {beta} agonist in a mouse model of global ischaemia. / Carswell, Hilary; Macrae, I.M.; Gallagher, L.; Harrop, E.; Horsburgh, K.J.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 287, No. 4, IDS Number: 854IH , 10.2004, p. H1501-H1504.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuroprotection by a selective oestrogen receptor {beta} agonist in a mouse model of global ischaemia

AU - Carswell, Hilary

AU - Macrae, I.M.

AU - Gallagher, L.

AU - Harrop, E.

AU - Horsburgh, K.J.

PY - 2004/10

Y1 - 2004/10

N2 - The present study employs selective estrogen receptor (ER) agonists to determine whether 17-estradiol-induced neuroprotection in global ischemia is receptor mediated and, if so, which subtype of receptor (ERα or ER) is predominantly responsible. Halothane-anesthetized female C57Bl/6J mice were ovariectomized, and osmotic minipumps containing ER agonist diarylpropiolnitrile (DPN) (8 mg·kg–1·day–1, n = 12) or vehicle (50% DMSO in 0.9% saline) (n = 9) or ERα agonist propyl pyrazole triol (PPT) (2 mg·kg–1·day–1, n = 13) or vehicle (50% DMSO in 0.9% saline) (n = 10) were implanted subcutaneously. One week later transient global ischemia was induced by bilateral carotid artery occlusion under halothane anesthesia, and the mice were perfusion fixed 72 h later. ER agonist DPN significantly reduced ischemic damage by 70% in the caudate nucleus and 55% in the CA1 region compared with vehicle controls (P < 0.05, Mann-Whitney U-statistic). In contrast, pretreatment with the ERα agonist PPT had no effect on the extent of neuronal damage compared with controls. The data indicate a significant estrogen receptor-mediated neuroprotection in a global cerebral ischemia model involving ER.

AB - The present study employs selective estrogen receptor (ER) agonists to determine whether 17-estradiol-induced neuroprotection in global ischemia is receptor mediated and, if so, which subtype of receptor (ERα or ER) is predominantly responsible. Halothane-anesthetized female C57Bl/6J mice were ovariectomized, and osmotic minipumps containing ER agonist diarylpropiolnitrile (DPN) (8 mg·kg–1·day–1, n = 12) or vehicle (50% DMSO in 0.9% saline) (n = 9) or ERα agonist propyl pyrazole triol (PPT) (2 mg·kg–1·day–1, n = 13) or vehicle (50% DMSO in 0.9% saline) (n = 10) were implanted subcutaneously. One week later transient global ischemia was induced by bilateral carotid artery occlusion under halothane anesthesia, and the mice were perfusion fixed 72 h later. ER agonist DPN significantly reduced ischemic damage by 70% in the caudate nucleus and 55% in the CA1 region compared with vehicle controls (P < 0.05, Mann-Whitney U-statistic). In contrast, pretreatment with the ERα agonist PPT had no effect on the extent of neuronal damage compared with controls. The data indicate a significant estrogen receptor-mediated neuroprotection in a global cerebral ischemia model involving ER.

KW - neuroprotector

KW - oestrogen receptor

KW - mouse model

KW - global ischaemia

UR - http://ajpheart.physiology.org/content/287/4/H1501.full.pdf+html

U2 - 10.1152/ajpheart.00227.2004

DO - 10.1152/ajpheart.00227.2004

M3 - Article

VL - 287

SP - H1501-H1504

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4

M1 - IDS Number: 854IH

ER -